Yifeng Wang

Dr. Yifeng Wang

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 April 2018 in Journal of Cellular Biochemistry
Verified
Journal Article
Closed access
PDF file
YLYU LIU
YU LIU
LTLin Tong
Lin Tong
YLYan Luo
Yan Luo
XLXin Li
Xin Li
GCGaowen Chen
Gaowen Chen
YWYifeng Wang
Yifeng Wang

1 January 2018 in Technology in Cancer Research & Treatment
Verified
Journal Article
Open access
GCGaowen Chen
Gaowen Chen
LZLin Zhu
Lin Zhu
YYYulu Yang
Yulu Yang
YLYusheng Long
Yusheng Long
XLXiangyuan Li
Xiangyuan Li
YWYifeng Wang
Yifeng Wang
The aim of the study was to investigate the prognostic role of neutrophil to lymphocyte ratio in ovarian cancer. Growing number of articles reported the relationship between neutrophil to lymphocyte ratio and prognosis in ovarian cancer, but the results remains inconclusive. The meta-analysis was conducted to analyze the association of pretreatment neutrophil to lymphocyte ratio with overall survival and progression-free survival. We performed a systematic literature research of PubMed, EMBASE, Medline, and Cochrane library for relevant studies up to October 8, 2017. The quality of included studies was assessed by the Newcastle-Ottawa Quality Assessment Scale. The hazard ratio and corresponding 95% confidence intervals were calculated. We checked the heterogeneity by the Q test and Higgins I-squared statistic. Begg funnel plot and Egger linear regression test were also applied for ascertain publication bias. All of the statistical analyses were performed using STATA version 12.0. A total of 12 studies with 4046 patients were included in our study. The results indicated that depressed neutrophil to lymphocyte ratio was significantly correlated with higher overall survival (hazard ratio = 1.409, 95% confidence intervals = 1.112-1.786, P = .005) and progression-free survival (hazard ratio = 1.523, 95% confidence intervals = 1.187-1.955, P = .001) in ovarian cancer. Subgroup analysis by ethnicity of overall survival and progression-free survival showed that the prognostic effect of neutrophil to lymphocyte ratio was found both in Asians and Caucasians. Patients with depressed neutrophil to lymphocyte ratio had a higher overall survival and progression-free survival in ovarian cancer. This meta-analysis provided neutrophil to lymphocyte ratio as an available predictor of overall survival and progression-free survival for patients with ovarian cancer.

1 September 2019 in Molecular Therapy-Oncolytics
Verified
Journal Article
Open access
XRXiaohong Ruan
Xiaohong Ruan
ALAibin Liu
Aibin Liu
MZMeigong Zhong
Meigong Zhong
JWJihong Wei
Jihong Wei
WZWeijian Zhang
Weijian Zhang
YWYifeng Wang
Yifeng Wang
Leucine-rich-repeat-containing G protein-coupled receptors (LGRs) have been widely found to be implicated with development and progression in multiple cancer types. However, the clinical significance and biological functions of LGR6 in ovarian cancer remains unclear. In this study, LGR6 expression was mainly examined by immunohistochemistry. Functional assays in vitro and animal experiments in vivo were carried out to explore the effect of LGR6 on cancer stem cell (CSC) characteristics and chemotherapeutic responses in ovarian cancer cells. Luciferase assays and GSEA were used to discern the underlying mechanisms contributing to the roles of LGR6 in ovarian cancer. Here, we reported that LGR6 was upregulated in ovarian cancer, which positively correlated with poor chemotherapeutic response and progression survival in ovarian cancer patients. Loss-of-function assays showed that downregulating LGR6 abrogated the CSC-like phenotype and chemoresistance in vitro. More importantly, silencing LGR6 improved the chemoresistance of ovarian cancer cells to cisplatin in vivo. Mechanistic investigation further revealed that silencing LGR6 inhibited stemness and chemoresistance by repressing Wnt/β-catenin signaling. Collectively, our results uncover a novel mechanism contributing to LGR6-induced chemotherapeutic resistance in ovarian cancer, providing the evidence for LGR6 as a potential therapeutic target in ovarian cancer.

17 May 2024 in Science Advances
Verified
Journal Article
Open access
HSHaonan Song
Haonan Song
HJHaoyuan Jiang
Haoyuan Jiang
WHWeichu Hu
Weichu Hu
YHYan Hai
Yan Hai
YCYihuan Cai
Yihuan Cai
XYXiao Yi
Xiao Yi
Cervical cancer, primarily squamous cell carcinoma, is the most prevalent gynecologic malignancy. Organoids can mimic tumor development in vitro, but current Matrigel inaccurately replicates the tissue-specific microenvironment. This limitation compromises the accurate representation of tumor heterogeneity. We collected para-cancerous cervical tissues from patients diagnosed with cervical squamous cell carcinoma (CSCC) and prepared uterine cervix extracellular matrix (UCEM) hydrogels. Proteomic analysis of UCEM identified several tissue-specific signaling pathways including human papillomavirus, phosphatidylinositol 3-kinase–AKT, and extracellular matrix receptor. Secreted proteins like FLNA, MYH9, HSPA8, and EEF1A1 were present, indicating UCEM successfully maintained cervical proteins. UCEM provided a tailored microenvironment for CSCC organoids, enabling formation and growth while preserving tumorigenic potential. RNA sequencing showed UCEM-organoids exhibited greater similarity to native CSCC and reflected tumor heterogeneity by exhibiting CSCC-associated signaling pathways including virus protein-cytokine, nuclear factor κB, tumor necrosis factor, and oncogenes EGR1, FPR1, and IFI6. Moreover, UCEM-organoids developed chemotherapy resistance. Our research provides insights into advanced organoid technology through native matrix hydrogels.

23 March 2023 in Journal of Controlled Release
Verified
Journal Article
Closed access
XLXiaomei Liang
Xiaomei Liang
YYYulu Yang
Yulu Yang
CHChuanqing Huang
Chuanqing Huang
ZYZhibin Ye
Zhibin Ye
WLWujiang Lai
Wujiang Lai
YWYifeng Wang
Yifeng Wang

1 October 2017 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Closed access
YHYi Huang
Yi Huang
HHHao Huang
Hao Huang
MLMojuan Li
Mojuan Li
XZXiuqing Zhang
Xiuqing Zhang
YLYusong Liu
Yusong Liu
YWYifeng Wang
Yifeng Wang